Cargando…
Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK
INTRODUCTION: Protein tyrosine kinases (PTKs) are frequently overexpressed and/or activated in human malignancies, and regulate cancer cell proliferation, cellular survival, and migration. As such, they have become promising molecular targets for new therapies. The non-receptor PTK termed breast tum...
Autores principales: | Lofgren, Kristopher A, Ostrander, Julie H, Housa, Daniel, Hubbard, Gregory K, Locatelli, Alessia, Bliss, Robin L, Schwertfeger, Kathryn L, Lange, Carol A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262201/ https://www.ncbi.nlm.nih.gov/pubmed/21923922 http://dx.doi.org/10.1186/bcr2946 |
Ejemplares similares
-
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
por: Peng, Maoyu, et al.
Publicado: (2014) -
Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes
por: Tupper, J., et al.
Publicado: (2011) -
Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012) -
Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma
por: Liu, Xue-Kui, et al.
Publicado: (2013) -
Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3
por: Box, Carol, et al.
Publicado: (2023)